Nuria Rivas-Lozano
Murcia, MU, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Real-world treatment patterns and outcomes in moderate-to-severe SLE: findings from the Spanish SPOCS cohort.
Journal: Lupus science & medicine
Published: March 17, 2026
Clinical characteristics of patients with antisynthetase syndrome and dermatomyositis-type skin involvement: Insights from the Myo-Spain registry.
Journal: Seminars in arthritis and rheumatism
Published: March 07, 2026
Self-reported depression on the Lupus Impact Tracker questionnaire (LIT) is associated with glucocorticoid use and fibromyalgia in systemic lupus erythematosus, according to RELESSER-PROS registry data.
Journal: BMC rheumatology
Published: September 12, 2025
Validation of proposals for definitions of moderate and severe disease activity in SLE: impact on flares, quality of life, damage accrual, hospitalisations and mortality.
Journal: Lupus science & medicine
Published: August 06, 2025
Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study.
Journal: Seminars in arthritis and rheumatism
Published: May 08, 2025
Comorbidity clusters and their relationship with severity and outcomes of index diseases, in a large multicentre systemic lupus erythematosus cohort.
Journal: Lupus science & medicine
Published: April 13, 2025
Oral glucocorticoid patterns use in moderate to severe active SLE: insights from the Spanish SPOCS data.
Journal: Lupus science & medicine
Published: April 09, 2025
Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La.
Journal: Lupus
Published: April 01, 2025
Rapid response to anifrolumab in refractory systemic lupus erythematosus.
Journal: Medicina clinica
Published: December 25, 2024
Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry.
Journal: Arthritis research & therapy
Published: August 19, 2024
Mepolizumab efficacy and safety in patients with eosinophilic granulomatosis with polyangiitis in real practice: Data from a Spanish retrospective multicentric register from Rheumatology departments.
Journal: Reumatologia clinica
Published: April 16, 2024
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.
Journal: Lupus science & medicine
Published: November 09, 2023
Last Updated: 09/26/2026